|
Abionic EPFL - Ecole Polytechnique Fédérale de Lausanne Nicolas Durand Based on an innovative nanotechnology approach, Abionic will develop and provide fast and low-cost screening tests for portable medical diagnostic use. Based on an innovative nanotechnology approach, Abionic will develop and provide fast and low-cost screening tests for portable medical diagnostic use. As there are currently over 100 million people in Europe suffering from allergies, Abionic will firstly develop a novel personalized allergy diagnostic test that will allow patients to take the optimal medication. |
| Beschreibung |
| entrepreneurial ID |
| Videos, Slides & more |
|
|
Aktulle News aus dem Bereich Startup
direkt per E-Mail erhalten: